TFFP (TFF Pharmaceuticals) Short-Term Debt to Capital

Corporate company logo of TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals (TFFP) business relies on the success of licensing inhalation methods and the stability of powder form production. This chart reflects the current market value on GURU.Markets at 0.02, which correlates with a transparent process of patent sales and the firm's liquidation due to a funding deficit. The company is currently stagnating: operational activities have ceased, and drug freezing developments are completely frozen.

Ratio of Short-Term Indebtedness to Capital: TFF Pharma (TFFP) for 07/04/2022 - 12/21/2024

Analytical breakdowns for TFF Pharmaceuticals

- stock quotes and analyst forecast:
Stock Price TFF Pharma|TFFP - Fair Value Consensus
- business market valuation indicators:
Market Capitalization TFF Pharmaceuticals Inc.|TFFP - Enterprise Value
- book capitalization information:
Net Assets per Single Share TFF Pharmaceuticals|TFFP - Accounting Value of Company|Market Value to Book Value Ratio tffpharma.com|TFFP - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital TFF Pharmaceuticals|TFFP - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio TFF Pharmaceuticals, Inc.|TFFP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio TFF Pharmaceuticals Inc.|TFFP - Long-Term Debt|Company Current Liabilities TFF Pharmaceuticals|Quick Ratio tffpharma.com
- company profitability and valuation multiples indicators:
TFFP - Final Profit
Fundamental valuation:TFFP TFF Pharma
Brand item of TFF Pharmaceuticals Inc.

This ratio determines the issuer's financial stability through the relationship between short-term liabilities and equity, allowing the investor to assess liquidity risk and the degree of debt load. By analyzing the change in the ratio of short-term borrowed capital to equity, one can confirm the low capital expenditure requirements of TFF Pharmaceuticals (TFFP), as the use of contract manufacturing organizations (CMO) minimizes the need for costly plant ownership.

Competitors of TFF Pharmaceuticals (TFFP)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|BioHarvest Sciences Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio EXOZ (Invizyne Technologies)|Oramed Pharma - Short-Term Debt to Capital|Current Liabilities to Equity ENTX|HYFT: Short-Term Debt to Capital|Current Liabilities to Equity ABVC (abvcpharma.com)|Short-Term Debt to Equity Ratio CPIX|QNTM: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity FibroGen Corp (FGEN)|TELO: Current Liabilities to Equity|Short-Term Debt to Capital RANI (Rani Therapeutics Holdings, Inc.)|Ratio of Short-Term Indebtedness to Capital SNYR|Rallybio Corp. - Short-Term Debt to Capital|LEXX - Short-Term Debt to Capital|Pulmatrix Corp (PULM) - Short-Term Debt to Equity|Pheton Holdings - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Aptorum Group Ltd|Short-Term Debt to Equity Ratio lyratherapeutics.com (LYRA)|Short-Term Debt to Capital IBO|Short-Term Debt to Capital tnfpharma.com (TNFA)|Short-Term Debt to Capital YCBD (cbdMD)|PRFX - Short-Term Debt to Equity Ratio|Auris Medical - Short-Term Debt to Capital|Current Liabilities to Capital lipella.com|OPTN (OptiNose) - Short-Term Debt to Equity Ratio|Pieris Pharmaceuticals Inc (PIRS) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PROC|PTPI (Petros Pharma) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital QLI|Short-Term Debt to Capital Coefficient acelyrin.com